Alpine Immune Sciences In... (ALPN)
NASDAQ: ALPN
· Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM
Alpine Immune Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.03M | 30.85M | 10.04M | 8.59M | 9.39M | 2.78M | 8.37M | 5.29M | 13.63M | 4.53M | 8.52M | 7.19M | 3.2M |
Cost of Revenue | 22.46M | 148K | 146K | 142K | 140K | 145K | 148K | 156K | 148K | 138K | 18.31M | 14.63M | 10.44M |
Gross Profit | -15.43M | 30.7M | 9.9M | 8.45M | 9.25M | 2.63M | 8.22M | 5.14M | 13.48M | 4.39M | -9.79M | -7.44M | -7.23M |
Operating Income | -22.7M | 1.55M | -14.55M | -15.65M | -15.59M | -20.37M | -13.83M | -16.49M | -7.46M | -15.38M | -13.26M | -10.73M | -10.49M |
Interest Income | 4.78M | 4.01M | 2.89M | 2.53M | 2.42M | 2.17M | 664K | 314K | 145K | 93K | 52K | 51K | 63K |
Pretax Income | -17.92M | 6.06M | -11.72M | -13.16M | -13.27M | -18.32M | -13.27M | -16.32M | -7.52M | -15.46M | -13.41M | -10.9M | -10.64M |
Net Income | -17.92M | 5.96M | -11.72M | -13.16M | -11.01M | -18.86M | -12.71M | -18.1M | -7.53M | -15.17M | -13.49M | -11.03M | -10.64M |
Selling & General & Admin | 7.27M | 6.37M | 5.44M | 5.01M | 5.4M | 4.39M | 4.61M | 4.19M | 4.78M | 4.54M | 3.47M | 3.29M | 3.26M |
Research & Development | 22.46M | 22.78M | 19.15M | 19.24M | 19.58M | 18.76M | 17.59M | 17.59M | 16.31M | 15.36M | 18.31M | 14.63M | 10.44M |
Other Expenses | n/a | n/a | -63K | -1K | -22K | -25K | n/a | -15K | -57K | -4K | n/a | n/a | n/a |
Operating Expenses | 29.73M | 29.16M | 24.59M | 24.25M | 24.98M | 23.14M | 22.2M | 21.78M | 21.09M | 19.91M | 21.78M | 17.92M | 13.69M |
Interest Expense | n/a | n/a | n/a | 28K | 70K | 87K | 105K | 130K | 154K | 178K | 203K | 218K | 217K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.73M | 29.31M | 24.59M | 24.25M | 24.98M | 23.14M | 22.2M | 21.78M | 21.09M | 19.91M | 21.78M | 17.92M | 13.69M |
Income Tax Expense | n/a | 103K | -63K | 27K | -2.26M | 548K | -559K | 1.78M | 4K | -298K | 80K | 131K | 63K |
Shares Outstanding (Basic) | 64.03M | 60.35M | 49.22M | 48.05M | 47.57M | 45.88M | 31.57M | 30.32M | 30.27M | 29.14M | 24.72M | 23.91M | 23.87M |
Shares Outstanding (Diluted) | 64.03M | 60.35M | 49.22M | 48.05M | 47.57M | 45.88M | 31.57M | 30.32M | 30.27M | 29.35M | 24.72M | 23.91M | 23.87M |
EPS (Basic) | -0.28 | 0.10 | -0.24 | -0.27 | -0.23 | -0.41 | -0.4 | -0.6 | -0.25 | -0.52 | -0.55 | -0.46 | -0.45 |
EPS (Diluted) | -0.28 | 0.10 | -0.24 | -0.27 | -0.23 | -0.41 | -0.4 | -0.6 | -0.25 | -0.52 | -0.55 | -0.46 | -0.45 |
EBITDA | -22.55M | 1.7M | -11.58M | -12.99M | -13.2M | -18.23M | -13.02M | -16.03M | -7.22M | -15.29M | -13.06M | -10.52M | -10.26M |
EBIT | -22.7M | 5.87M | n/a | -13.13M | -13.2M | -18.23M | -13.17M | -16.19M | -7.37M | -15.29M | -13.21M | -10.68M | -10.43M |
Depreciation & Amortization | 147K | 148K | 146K | 142K | 2.4M | 2.14M | 812K | 455K | 236K | 138K | 155K | 162K | 165K |